Community Healthcare Trust Incorporated (CHCT)

Executive Summary / Key Takeaways

• CHCT has pivoted to a capital recycling strategy, funding acquisitions through asset sales rather than equity issuance at depressed valuations, creating a potential arbitrage between 7.5-8% disposition cap rates and 9-10% acquisition yields that could drive accretive growth without diluting shareholders.

• The overhang from a distressed geriatric behavioral hospital tenant, which has forced $19.7 million in credit reserves and reduced quarterly rent from $800,000 to $200,000, represents a significant risk to cash flows and dividend sustainability, though management expects resolution via sale to a new operator in Q1 2026.

• Trading at 0.97x book value with a 12.21% dividend yield, the market is pricing in significant stress, yet the company's 90.6% occupancy and 7-year weighted average lease term suggest underlying portfolio stability that could re-rate higher if management executes on its pipeline and resolves the tenant issue.

• The dividend, while covered by AFFO at an 85% payout ratio, remains vulnerable to further tenant deterioration or failed capital recycling execution, making the next 6-12 months critical for determining whether this is a value trap or a contrarian opportunity.

Setting the Scene: A Niche REIT Forced to Adapt

Community Healthcare Trust Incorporated, founded in Maryland in 2014 and headquartered in Franklin, Tennessee, operates as a self-managed healthcare REIT with a deliberate focus on non-urban medical properties. The company makes money by acquiring healthcare real estate—primarily medical office buildings, inpatient rehab facilities, and behavioral health centers—and leasing them to hospitals, physician groups, and healthcare systems on long-term net leases. This strategy targets the $3 million to $30 million property size range, where management believes there is "significantly less competition from existing REITs and institutional buyers," creating opportunities for attractive risk-adjusted returns.

The company's place in the industry structure reveals both its opportunity and its constraint. Unlike giants such as Welltower (WELL) and Omega Healthcare (OHI) with multi-billion dollar portfolios spanning seniors housing and large-scale medical campuses, CHCT's $1.2 billion portfolio of 198 properties represents a niche player focused on community-based healthcare delivery. This positioning aligns with a powerful secular trend: outpatient volumes are projected to grow by double-digits over the next five years as care shifts from hospitals to decentralized, community-based settings. The company's 34-state footprint, with concentrations in Texas (14.3% of rent) and Florida (12.4%), captures markets with favorable demographic trends, though this geographic concentration also creates localized economic risk.

What makes CHCT's current situation distinct is how it has been forced to adapt its capital allocation. Since its 2015 IPO, the company grew steadily through equity issuance, with executives even taking 100% of compensation in restricted stock through 2023 to align with shareholders. However, a low share price has rendered its at-the-market equity program uneconomical, forcing management to fund growth exclusively through capital recycling—selling assets at 7.5-8% cap rates and reinvesting proceeds into 9-10% yielding acquisitions. This pivot from external to internal funding sources represents the central strategic inflection point that will define the company's trajectory over the next 18-24 months.

Strategic Differentiation: Off-Market Deals and Capital Arbitrage

CHCT's core competitive advantage lies in its ability to source off-market or lightly marketed transactions in submarkets that larger REITs overlook. This isn't merely a sourcing tactic; it translates directly into pricing power and occupancy stability. The company's 90.6% leased occupancy as of December 31, 2025, while not exceptional, reflects consistent demand for its properties in markets where supply is constrained and competition is limited. The weighted average remaining lease term of 7 years provides cash flow visibility that supports the dividend, while built-in rent escalators create organic growth.

The capital recycling program operationalizes this advantage into a funding strategy. In Q4 2025, CHCT sold an inpatient rehab facility at a 7.9% cap rate, generating an $11.5 million gain, and reinvested the proceeds through a 1031 exchange into a new $28.5 million facility yielding 9.3%. This 140 basis point spread on invested capital creates immediate accretion to AFFO per share while reducing concentration risk. Management has signaled similar dispositions will fund the $122.5 million acquisition pipeline, which offers yields of 9.1% to 9.75%. The strategy is elegant in theory: harvest value from mature assets and redeploy into higher-yielding properties without increasing leverage or issuing dilutive equity.

The significance lies in the material execution risk. Capital recycling requires precise timing—gaps between sales and acquisitions can pressure quarterly results, as management acknowledged when noting "a little bit of a gap" in Q4. More importantly, the strategy assumes a liquid market for dispositions and stable acquisition yields. If cap rates widen on either side of the trade, the arbitrage collapses. The company's modest leverage policy, which prohibits debt exceeding 45% of total capitalization except for short-term periods, provides some cushion but also limits financial flexibility if asset sales disappoint.

Financial Performance: Tenant Distress Masks Underlying Stability

CHCT's financial results tell a story of growth overshadowed by tenant-specific stress. Total revenue grew 5.9% to $121.35 million in 2025, driven by $5.4 million from acquisitions, $0.9 million from cash-basis tenants, and $1.8 million from rent escalators and lease commencements. This growth is respectable for a REIT of CHCT's size, but the composition reveals pressure points. The $1.1 million revenue decline from sold properties and the $0.2 million net decrease in allowance for doubtful accounts indicate management is actively pruning the portfolio while managing credit risk.

The geriatric behavioral hospital operator situation represents the most significant financial headwind. The tenant, which operates six properties, paid only $200,000 in Q4 2025 rent versus a historical $800,000 quarterly rate. CHCT recorded $11 million in credit loss reserves in 2024 and an additional $8.7 million in 2025, fully reserving the notes receivable. This $19.7 million total reserve represents 1.6% of gross investments, but the cash flow impact is more severe: the $2.4 million annual rent reduction equates to a 2% hit to total revenue. Management has recognized rent on a cash basis since collectibility is not reasonably assured, creating quarterly volatility and uncertainty.

General and administrative expenses increased $6 million in 2025, a 31.7% jump that includes $4.6 million in non-cash accelerated amortization and $1.3 million in severance costs from the departure of the former Executive Vice President of Asset Management. While these are one-time items, they highlight the organizational stress of managing through the tenant situation and leadership transition. The new Senior Vice President of Asset Management, Mark Kearns, who joined in May 2025 with 25 years of experience, must stabilize operations while executing the capital recycling strategy.

Funds from operations (FFO) of $45.88 million and adjusted FFO (AFFO) of $58.37 million in 2025 provide coverage for the $1.91 annual dividend per share, but the margin is thin. The Q2 2025 severance and interest reversal charges reduced FFO by $0.28 per share and AFFO by $0.06 per share, demonstrating how quickly tenant and operational issues can compress cash flow. With a 12.21% dividend yield, the market is pricing in a cut, yet management has increased the dividend every quarter since IPO, making the dividend a priority for its investor base.

Outlook: Tenant Resolution and Occupancy Inflection

Management's guidance for 2026 hinges on two critical variables: resolution of the geriatric behavioral hospital tenant situation and occupancy improvement from redevelopment projects. The tenant signed a letter of intent on July 17, 2025, to sell all six hospital operations to an experienced behavioral healthcare operator, with the buyer expected to sign new or amended leases with CHCT. Management emphasizes the goal is a single transaction for all six hospitals, not a staged closing, which reduces execution risk but concentrates timing risk. While the transaction was initially expected to close by year-end 2025, due diligence delays have pushed the realistic timeline to Q1 2026.

The quality of the prospective operator matters significantly. Management describes the buyer as having "a great deal of experience broadly within the behavioral health care space" and "specifically in geriatric psych," with "strong large platform and good financial resources." If the transaction closes with market-rate leases, CHCT could recover a meaningful portion of the lost rent while eliminating the credit overhang. However, management has cautioned investors not to expect a full recovery of the reserved amounts, suggesting any lease restructuring may involve rent concessions or deferred payments. The company is simultaneously pursuing multiple paths, indicating active negotiation but also signaling that patience is not unlimited.

Occupancy improvement represents the second growth driver. The leased occupancy rate increased from 90.1% to 90.6% in Q4 2025, and management expects this "low 90s" range to persist for the next couple of quarters before accelerating in the second half of 2026. Three properties undergoing redevelopment are expected to contribute, with the largest project completing in Q2 2026 and rent commencing in Q3 2026. These projects provide embedded growth without incremental capital deployment, though the timeline suggests near-term AFFO per share growth will remain modest.

The $122.5 million acquisition pipeline, with expected returns of 9.1% to 9.75%, remains on track for closings in 2026 and 2027. Management's commitment to funding these deals through capital recycling rather than the $300 million ATM program demonstrates discipline but also acknowledges the stock is too cheap to use as currency. The key execution metric will be the spread between disposition and acquisition cap rates; maintaining a 150-200 basis point gap while completing $30-40 million in quarterly sales is essential for accretive growth.

Risks: Where the Thesis Can Break

The investment thesis faces three material risks that could transform CHCT from a value opportunity into a value trap. First, failure to resolve the geriatric behavioral hospital tenant situation would crystallize a permanent loss of $2.4 million in annual rent and potentially trigger impairment on the $8.7 million in fully reserved notes. While management has pursued multiple paths, the behavioral healthcare sector faces regulatory headwinds from the One Big Beautiful Bill Act (OBBBA) of 2025 , which reduced Medicaid funding and could cause millions to lose coverage by 2034. If the prospective buyer's financing or licensure is delayed beyond Q1 2026, CHCT may need to find alternative operators, likely at lower rent rates.

Second, the capital recycling strategy could falter if disposition markets weaken. The company targets 7.5% to 8% cap rates on sales, but rising interest rates or healthcare real estate market softness could force sales at less attractive pricing. With $258 million outstanding on its revolving credit facility and $275 million in term loans, CHCT has $142 million in remaining capacity, but its debt-to-total capitalization ratio of 42.9% approaches the 45% policy limit. If asset sales stall, the company may be forced to fund acquisitions with debt, increasing leverage and interest expense, or suspend the dividend to preserve capital. The 13.8% increase in interest expense in 2025, driven by higher rates on hedged debt, already demonstrates margin pressure from leverage.

Third, dividend sustainability remains a critical vulnerability. While AFFO covered the dividend at an 85% payout ratio in Q3 2025, this leaves minimal cushion for operational setbacks. The 12.21% dividend yield signals market skepticism about maintenance. If the tenant situation deteriorates further or capital recycling creates cash flow gaps, management may face the difficult choice of cutting the dividend to protect the balance sheet. Such a cut would likely trigger forced selling from income-focused investors and could drive the stock price materially lower.

Geographic concentration amplifies these risks. With 26.7% of annualized rent from Texas and Florida, and nearly half of total revenues from Texas, Illinois, Florida, and Ohio, localized economic downturns or healthcare policy changes could create simultaneous tenant stress across multiple properties. The watch list of 15 to 20 tenants indicates active credit management but also reveals underlying portfolio risk that could escalate in a recession.

Competitive Context: Small Scale, Niche Focus

CHCT's competitive positioning reveals a classic small-cap REIT dilemma: specialized expertise versus scale disadvantage. Compared to Sabra Health Care REIT (SBRA) with $7.4 billion in enterprise value and 23.7% operating margins, CHCT's $970 million enterprise value and 19.6% operating margin reflect its smaller scale and higher cost of capital. SBRA's diversified portfolio across skilled nursing and outpatient properties provides stability that CHCT's pure outpatient focus cannot match, though CHCT's 7-year WALT exceeds SBRA's typical lease terms, providing longer cash flow visibility.

National Health Investors (NHI) demonstrates the benefits of a conservative balance sheet, with debt-to-equity of 0.92 versus CHCT's 1.25, and operating margins of 62.6% driven by master lease structures. However, NHI's heavy concentration in senior housing exposes it to demographic headwinds, while CHCT's outpatient focus aligns with the shift to ambulatory care. This strategic positioning gives CHCT a qualitative edge in growth markets, but NHI's scale allows it to access better financing terms and larger, more liquid assets.

Omega Healthcare and Welltower dominate the healthcare REIT landscape with $17.8 billion and $153 billion enterprise values, respectively. Their massive scale enables them to serve as "one-stop" partners for large health systems, a role CHCT cannot play. However, their size also makes it difficult to pursue sub-$30 million properties where CHCT faces "significantly less competition." This niche focus allows CHCT to achieve comparable occupancy rates while capturing higher yields, though the company's 1.13% return on equity lags OHI's 12% and WELL's 2.5%, reflecting the drag from tenant issues and smaller asset base.

The key competitive differentiator is CHCT's ability to move quickly on off-market deals. While WELL requires months of committee approval for its $11 billion investment pipeline, CHCT can close $3-30 million properties with minimal bureaucracy. This agility is valuable in fragmented markets but becomes a liability when capital markets are closed, as the company cannot issue equity to fund accretive deals. The capital recycling strategy attempts to turn this weakness into a strength, but it requires flawless execution in volatile markets.

Valuation Context: Discounted for Distress

At $15.52 per share, CHCT trades at a 3% discount to book value of $15.93 and offers a 12.21% dividend yield, metrics that typically signal deep value or fundamental distress. The price-to-free-cash-flow ratio of 12.4x and EV/EBITDA of 12.9x sit modestly above healthcare REIT averages, but the P/E ratio of 194x reflects the earnings drag from tenant reserves and severance charges. These valuation multiples are best understood within the context of the company's strategic inflection.

The enterprise value of $970 million represents 8.0x revenue, a discount to SBRA's 9.6x and OHI's 15.0x. More telling is the EV/EBITDA multiple of 12.9x versus SBRA's 16.6x and OHI's 16.7x, suggesting the market is pricing in EBITDA recovery. The debt-to-equity ratio of 1.25x is higher than SBRA's 0.90x and OHI's 0.79x, reflecting CHCT's reliance on leverage in the absence of equity issuance.

The dividend yield spread over the 10-year Treasury of approximately 900 basis points indicates extreme market skepticism about sustainability. For context, SBRA yields 6.1% and OHI yields 6.0%, making CHCT's 12.2% yield an outlier. The explanation lies in the tenant overhang and capital recycling execution risk. If management resolves the behavioral hospital situation at or near historical rent levels and demonstrates consistent capital recycling accretion, the yield should compress toward sector norms, implying 30-40% upside potential. Conversely, if the tenant defaults or the dividend is cut, the stock could trade down to 0.7-0.8x book value, representing 15-25% downside.

Conclusion: Execution at an Inflection Point

Community Healthcare Trust sits at a critical juncture where strategic discipline meets operational stress. The company's pivot to capital recycling is a response to a stock price that fails to reflect asset value, creating a potential arbitrage that could drive accretive growth without dilution. However, this strategy's success depends entirely on management's ability to execute dispositions at target cap rates while simultaneously resolving its largest tenant distress situation.

The investment thesis boils down to two variables: the timing and terms of the geriatric behavioral hospital sale, and the consistency of capital recycling spreads. If the Q1 2026 transaction closes with a creditworthy operator paying market rent, CHCT will eliminate its largest earnings drag and demonstrate the portfolio's underlying resilience. If capital recycling maintains a 150+ basis point spread between disposition and acquisition yields, the company can fund its $122.5 million pipeline while slowly deleveraging, setting the stage for dividend growth resumption.

The 12.21% dividend yield reflects legitimate concerns about coverage and tenant risk, but it also compensates investors for uncertainty. With a 7-year WALT, 90.6% occupancy, and no tenant exceeding 10% of rent, the portfolio's core cash generation capacity remains intact. The question is whether management can navigate the next six months without a dividend cut or leverage spike. Success would likely drive a re-rating toward sector-average yields, while failure would validate the market's skepticism. For investors willing to underwrite execution risk, the risk/reward is asymmetrically skewed to the upside—but the margin for error is thin.